Lilly experimental ‘triple G’ obesity drug leads to 24.2% weight loss in trial
By Deena Beasley (Reuters) -Eli Lilly on Monday said a mid-stage trial of its next-generation obesity drug candidate “triple G” showed that it led to weight loss of up to 24.2% after…
